当前位置: X-MOL 学术J. Crohns Colitis › 论文详情
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD Patients
Journal of Crohn's and Colitis ( IF 7.827 ) Pub Date : 2019-08-29 , DOI: 10.1093/ecco-jcc/jjz151
Bram Verstockt; Evelien Mertens; Erwin Dreesen; An Outtier; Maja Noman; Sophie Tops; Ganel Schops; Gert Van Assche; Séverine Vermeire; Ann Gils; Marc Ferrante

Vedolizumab has demonstrated efficacy and safety in patients with Crohn's disease [CD] and ulcerative colitis [UC]. Endoscopic outcome data are limited, especially in anti-tumour necrosis factor [TNF] naïve patients. The present study compared endoscopic outcome in anti-TNF naïve and exposed patients, and explored if this was affected by drug exposure.
更新日期:2020-04-17

 

全部期刊列表>>
智控未来
聚焦商业经济政治法律
跟Nature、Science文章学绘图
控制与机器人
招募海内外科研人才,上自然官网
隐藏1h前已浏览文章
课题组网站
新版X-MOL期刊搜索和高级搜索功能介绍
ACS材料视界
x-mol收录
湖南大学化学化工学院刘松
上海有机所
廖良生
南方科技大学
西湖大学
伊利诺伊大学香槟分校
徐明华
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug